Pay in 4 interest-free payments of $7.01 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
About Pemvidutide Pemvidutide is a novel, investigational peptide with balanced 1:1 glucagon/GLP-1 dual receptor agonist activity, in development for the treatment of metabolic dysfunction-associated steatohepatitis (MASH), alcohol use disorder (AUD) and alcohol-associated liver disease (ALD)
If this pattern holds for retatrutide, nasal delivery could offer a GI-tolerability advantage for individuals who respond well to the central appetite effects but struggle with peripheral GI symptoms
Contrave is FDA-approved for chronic weight management in adults with a BMI of 30 or higher (obesity), or a BMI of 27 or higher with at least one weight-related condition such as type 2 diabetes, high blood pressure, or high cholesterol
A generic formulation that achieves the same clinical performance as the branded product through a different polymer matrix, a different excipient system, or a different device mechanism does not infringe the branded delivery patents
US$ 29.17
US$ 25.86
US$ 27.13
US$ 23.94
US$ 24.56
US$ 24.19
US$ 23.83
